The pharmacokinetics of doxazosin in elderly normotensives.
- 1 May 1986
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 21 (5) , 521-524
- https://doi.org/10.1111/j.1365-2125.1986.tb02835.x
Abstract
The pharmacokinetics of doxazosin were studied in 12 normotensive elderly volunteers aged 62‐89 years. There was marked inter‐individual variability in all the parameters derived but the disposition of doxazosin was similar in both sexes. These results were compared to those of a group of young normotensive volunteers aged 23‐39 years studied previously under comparable conditions. The volume of distribution increased significantly with age although the bioavailability and clearance were not significantly different in the two groups. These results suggest that age is unlikely to influence the disposition of doxazosin to a clinically significant extent.This publication has 15 references indexed in Scilit:
- Clinical Pharmacokinetics of Prazosin - 1985Clinical Pharmacokinetics, 1985
- A pharmacodynamic and pharmacokinetic assessment of a new alpha‐ adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.British Journal of Clinical Pharmacology, 1982
- Prazosin disposition in young and elderly subjects.British Journal of Clinical Pharmacology, 1981
- Disposition of Antipyrine and Phenytoin Correlated with Age and Liver Volume in ManClinical Pharmacokinetics, 1981
- Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Pharmacokinetics in the ElderlyClinical Pharmacokinetics, 1976
- Pharmacokinetics in the aged: A reviewJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Sex Difference in Blood Levels of some AntibioticsChemotherapy, 1973
- RAPID EVALUATION OF CREATININE CLEARANCEThe Lancet, 1971
- Serum Protein Patterns in ‘Normal’ and Pathological AgeingGerontology, 1964